These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33549765)

  • 1. Re: 'Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis' by Tleyjeh et al.
    Koeckerling D; Pan D; Barker J
    Clin Microbiol Infect; 2021 Aug; 27(8):1175-1176. PubMed ID: 33549765
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply.
    Kashour T; Tleyjeh IM
    Clin Microbiol Infect; 2021 Aug; 27(8):1177-1178. PubMed ID: 33705848
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis.
    Luo L; Luo T; Du M; Mei H; Hu Y
    J Infect; 2022 Mar; 84(3):418-467. PubMed ID: 34808242
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis.
    Rezaei S; Fatemi B; Karimi Majd Z; Minaei H; Peikanpour M; Anjidani N; Taheri A; Dastan F; Mosaed R
    Expert Rev Clin Immunol; 2021 May; 17(5):499-511. PubMed ID: 33823733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.
    Tleyjeh IM; Kashour Z; Damlaj M; Riaz M; Tlayjeh H; Altannir M; Altannir Y; Al-Tannir M; Tleyjeh R; Hassett L; Kashour T
    Clin Microbiol Infect; 2021 Feb; 27(2):215-227. PubMed ID: 33161150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to Tleyjeh.
    Malgie J; Schoones JW; Pijls BG
    Clin Infect Dis; 2021 Jun; 72(12):e1155-e1156. PubMed ID: 33340049
    [No Abstract]   [Full Text] [Related]  

  • 7. In COVID-19, tocilizumab reduces all-cause mortality at 28 d.
    Fernando SM; Rochwerg B
    Ann Intern Med; 2021 Jun; 174(6):JC63. PubMed ID: 34058104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.
    Tleyjeh IM; Kashour Z; Riaz M; Hassett L; Veiga VC; Kashour T
    Clin Microbiol Infect; 2021 Aug; 27(8):1076-1082. PubMed ID: 33915284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
    Yang C; Liu E; Liu M
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30025-30026. PubMed ID: 33184179
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.
    Cortegiani A; Ippolito M; Greco M; Granone V; Protti A; Gregoretti C; Giarratano A; Einav S; Cecconi M
    Pulmonology; 2021; 27(1):52-66. PubMed ID: 32713784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
    Peng J; She X; Mei H; Zheng H; Fu M; Liang G; Wang Q; Liu W
    Aging (Albany NY); 2022 Jan; 14(2):557-571. PubMed ID: 35038318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials.
    Lin WT; Hung SH; Lai CC; Wang CY; Chen CH
    Int Immunopharmacol; 2021 Jul; 96():107602. PubMed ID: 33812260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19).
    Ullah S; Abid R; Haider S; Khuda F; Albadrani GM; Abdulhakim JA; Altyar AE; Abdel-Daim MM; Halimi SMA; Khalil AAK
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease.
    Samaee H; Mohsenzadegan M; Ala S; Maroufi SS; Moradimajd P
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107018. PubMed ID: 33045577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis.
    Peng J; Fu M; Mei H; Zheng H; Liang G; She X; Wang Q; Liu W
    Rev Med Virol; 2022 May; 32(3):e2295. PubMed ID: 34558756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.
    Lo CKL; Chagla Z
    Ann Intern Med; 2021 Nov; 174(11):JC125. PubMed ID: 34724398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab-Associated Cecal Perforation in COVID-19 Pneumonia.
    Adunse J; Kesireddy N; Khokher W; Mudiyanselage PH; Ali H; Assaly R
    Am J Ther; 2022 Jul; 29(4):473-475. PubMed ID: 34010161
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic.
    Mahroum N; Watad A; Bridgewood C; Mansour M; Nasr A; Hussein A; Khamisy-Farah R; Farah R; Gendelman O; Lidar M; Shoenfeld Y; Amital H; Kong JD; Wu J; Bragazzi NL; McGonagle D
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab: From Rheumatic Diseases to COVID-19.
    Raiteri A; Piscaglia F; Granito A; Tovoli F
    Curr Pharm Des; 2021; 27(13):1597-1607. PubMed ID: 33719967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.